People who write and submit articles on behalf of the pharmaceutical, biotechnology, and medical device industries should ensure accuracy and completeness and avoid any practices that promote commercial products when developing research communications, an updated international code of ethics recommends.

The International Society for Medical Publications Professionals, an independent, not for profit organisation, has revised its code of ethics in line with evolving developments in medical publishing. The aim is to ensure integrity and transparency in the publication of medical research.

Several recent reports have raised …